AXA SA (AXA:CA) Presents at European Financials Conference 2026 Transcript

AXA delivered FY25 top-line growth of 6% and UEPS growth of 8%, hitting the top end of its targets. Newly appointed Global Head Guillaume Borie said the group is in very good shape and reiterated a commitment to deliver at the top end of its 2026 guidance range, signaling confidence in execution.

Analysis

AXA’s strategic emphasis on underwriting, risk segmentation and tech creates convexity: marginal capital can be redeployed into higher-return specialty lines or distribution buys faster than for peers with heavier legacy life footprints. That optionality means a near-term earnings beat (if sustained) is not just operational — it materially changes capital allocation choices (buybacks, M&A, release of capital to shareholders) over the next 6–18 months, shifting investor returns from yield to realized capital returns.

A key second-order dynamic is reinsurance supply elasticity. If reinsurance rates stay firm through the next two renewal cycles, AXA captures mechanically higher underwriting margins; if capacity returns (or catastrophes spike), combined ratios can re-widen quickly. Interest-rate moves remain the dominant macro swing: a 50–100bp fall in term rates over 12 months would force reinvestment drag and expose life reserve sensitivity, while a stable-to-rising curve buys time for capital redeployment.

Catalysts to watch are the June/January reinsurance renewals, any announced capital returns or bolt-on M&A within 3–12 months, and quarterly reserve development that would reveal underwriting trend durability. Near-term tail risks: a major catastrophe season, a regulatory capital shock in France/Europe, or a multi-quarter fall in rates — any would reverse relative outperformance within months.

Consensus currently under-weights the timing of capital recycling: either it’s priced as permanent margin improvement (overoptimistic) or as transitory cyclical benefit (too bearish). My base-case is asymmetric upside over 6–18 months if reinsurance and rates cooperate; downside is concentrated and identifiable, making structured option exposure attractive.

Key Decisions for Investors

• Long AXA.PA via a 9–12 month call-spread (buy ATM 12-month call, sell 30% OTM 12-month call) — target 2.0–3.0x upside if AXA executes capital redeployment; max loss = premium paid. Entry trigger: stock pullback <10% from current levels or ahead of June reinsurance renewals.
• Pair trade: long AXA.PA / short ALV.DE equal notional, 6–12 month horizon — directional play on superior capital optionality and underwriting agility. Risk: sector-wide shock (cat loss or rates move) — size as market-neutral 3–5% portfolio exposure and trim if pair diverges >15% intrarelative.
• Buy short-dated put protection (3–6 month) on AXA.PA sized to cover 25–30% nominal downside while keeping equity upside, funded by selling 9–12 month OTM calls — cost-efficient hedge if catastrophe season or rate shock arrives. Exit/roll if reinsurance price signals move unfavorably by >5% at renewals.